In the mouse, embryological and genetic studies have indicated that two spatially distinct signalling centres, the anterior visceral endoderm and the node and its derivatives, are required for the correct patterning of the anterior neural ectoderm. The divergent homeobox gene Hex is expressed in the anterior visceral endoderm, in the node (transiently), and in the anterior definitive endoderm. Other sites of Hex expression include the liver and thyroid primordia and the endothelial cell precursors. We have used transgenic analysis to map the cis-acting regulatory elements controlling Hex expression during early mouse development. A 4.2-kb upstream region is important for Hex expression in the endothelial cell precursors, liver, and thyroid, and a 633-bp intronic fragment is both necessary and sufficient for Hex expression in the anterior visceral endoderm and the anterior definitive endoderm. These same regions drive expression in homologous structures in Xenopus laevis, indicating conservation of these regulatory regions in vertebrates. Analysis of the anterior visceral endoderm/ anterior definitive endoderm enhancer identifies a repressor region that is required to downregulate Hex expression in the node once the anterior definitive endoderm has formed. This analysis also reveals that the initiation of Hex expression in the anterior visceral endoderm and axial mesendoderm requires common elements, but maintenance of expression is regulated independently in these tissues.
INTRODUCTION
In the mouse, two spatially distinct signalling centres, the anterior visceral endoderm (AVE) and the node and its derivatives, are essential for the correct specification of the anterior neural ectoderm (Beddington and Robertson, 1999) . Embryological and genetic studies have indicated that the AVE is necessary for the initiation of the patterning of the anterior neural plate, whilst the node derivatives are required to maintain this pattern (reviewed by Martinez Barbera, 2001) . One interesting feature of both of these signalling tissues is that they express a similar repertoire of genes, including Hex, Lim1, HNF3␤, Otx2, Goosecoid (Gsc) , and Cerberus-like (Cerrl), suggesting not only that both these cell populations provide similar signals but also that they are regulated coordinately.
The divergent homeobox gene Hex is one of the earliest known markers of the AVE (Thomas et al., 1998) . Initially Hex is expressed in the primitive endoderm of the implanting blastocyst, but by 5.5 days postcoitum (dpc) Hex transcripts are confined to a small patch of visceral endoderm cells at the distal tip of the egg cylinder that are destined to give rise to the AVE. As these cells move to assume an anterior position, they continue to express Hex. This expression marks the earliest molecular anteroposterior asymmetry in the mouse embryo. At the early streak stage Hex is activated in the cells located at the anterior tip of the primitive streak. Fate mapping experiments, gene expression studies, and transplantation to assess patterning activity all indicate that these cells represent the progenitors of the morphologically recognizable node of the full-length streak stage embryo (Tam and Steiner, 1999) . As gastrulation proceeds Hex expression is observed in the most anterior axial mesendoderm (the anterior definitive endoderm or ADE), but is downregulated from the node region and other more posterior node derivatives. During later stages of development, sites of Hex expression include the nascent blood islands, liver, thyroid gland, lungs, endothelial cell precursors, and multipotent hematopoetic cells (Crompton et al., 1992; Keng et al., 1998; Thomas et al., 1998) . Analysis of Hex mutant embryos (Martinez Barbera et al., 2000) has revealed a requirement for this gene in the definitive endoderm for the normal formation of the liver, thyroid, and forebrain. Hex orthologues have been cloned in human, Xenopus, chick, and zebrafish (Bedford et al., 1993; Ho et al., 1999; Jones et al., 1999; Newman et al., 1997; Yatskievych et al., 1999) . In all these organisms, the main features of the Hex expression pattern appear to be conserved, indicating the possibility of evolutionary conservation not only of Hex function, but also of its regulation.
Here we have used a transgenic approach to map the cis-acting regulatory elements that control where Hex is expressed. We address whether distinct enhancer elements are required for the different locations of Hex expression and whether these may be sufficient for initiation and maintenance of expression. We have also tested whether these cis-acting sequences contain conserved elements that direct similar expression patterns in Xenopus.
MATERIALS AND METHODS

DNA Constructs for Transgenes
A Hex genomic clone was isolated from a 129/Ola library using the Hex cDNA as a probe (Martinez Barbera et al., 2000; Thomas et al., 1998) . For construct A, the eGFP reporter gene (Clontech ϪN2) was placed downstream of the ATG at the ApaI site and fragment A was excised with KpnI. Constructs B-B3 were generated by restriction-enzyme digestion of the 129/Ola genomic clone. SacII and SpeI were used for B, SacII and NheI for B1, NheI and SpeI for B2, and HpaI and NdeI for B3. The appropriate fragment was cloned into pBGZ40 (Yee and Rigby, 1993) , a vector carrying the human ␤-globin minimal promoter upstream of the lacZ reporter gene. B4 was generated by digestion of fragment A with NdeI. B5-B7 were generated by PCR amplification, digestion with XbaI, and cloning into pBGZ40. Primers used for this purpose were B5, 5Ј primer gctctagatgaaacaggtatcgacatggctc, 3Ј primer gctctagacttggcccttcccctctctc; B6, 5Ј primer as for B5, 3Ј primer gctctagacccttgagtcctgcctggtt; B7, 5Ј primer gctctagaccattatgccagggcttcaca, 3Ј primer as for B5. The construct used to produce transgenic Xenopus embryos carrying the AVE/ADE enhancer was generated by digestion of the 129/Ola genomic clone with NheI and SpeI. The fragment was cloned into the XbaI site of pBLCAT3T (a vector carrying the Xenopus cytoskeleton actin minimal promoter and the CAT reporter gene) (Casey et al., 1999) . A construct was considered to be expressed in a given pattern if three or more independent transgenic insertions gave this pattern of expression.
Transgenic Mice and Embryos
For microinjection, following digestion with appropriate restriction enzymes, inserts were separated from vector DNA by electrophoresis and purified using GeneClean (Anachem) following the instructions of the manufacturer. DNA was eluted in TE (10 mM Tris, 0.1 mM EDTA, pH 8). Transgenic embryos and mice were generated by pronuclear injection of a 1-2 ng/l DNA solution into fertilized mouse eggs from an intercross of F 1 hybrids (CBA/J ϫ C57BL6) and transferred to pseudopregnant (CBA/J ϫ C57BL6)F 1 females (Hogan et al., 1994; Whiting et al., 1991) . All mice were maintained on a 10-h-light, 14-h-dark cycle. Noon on the day of finding a vaginal plug was designated 0.5 dpc. For F 0 analysis, foster mothers were sacrificed and embryos retrieved for further study. For the analysis of transgenic lines, stud males were mated to (CBA/J ϫ C57BL6)F 1 females or to transgenic females that were derived from the same founder transgenic mouse. For the analysis of the activity of transgenic lines carrying construct B in Hex (Martinez Barbera et al., 2000) and HNF3␤ (Ang and Rossant, 1994) mutant embryos, crosses were established between Bϩ/Ϫ, Hexϩ/Ϫ males and Hexϩ/Ϫ females or between Bϩ/Ϫ, HNF3␤ϩ/Ϫ males and HNF3␤ϩ/Ϫ females.
Transgenic Xenopus Embryos and in Situ Hybridization
Transgenic Xenopus embryos were generated essentially as described (Kroll and Amaya, 1996) . DNA (100 to 250 ng) was FIG. 1. The Hex locus contains distinct cis-acting regulatory elements that control Hex expression during gastrulation and organogenesis. (A) The genomic organisation of the Hex locus is presented on the top line. Black boxes represent exons 1-4 and the ovals represent regions that are important for expression in the indicated tissues. Below are the constructs used to identify these regions. A schematic representation of the Hex-targeted allele is presented at the bottom of the figure. The expression pattern observed for each genomic subregion is indicated at the right of each construct. *Expression was only observed in embryos that were homozygous for construct B. The expression of B1-B3 and B5-B7 in the blood islands was considered as not determined (nd) because heterozygous embryos for these transgenes were analysed rather than homozygous embryos. 1 ϭ weak and in very few cells; 2 ϭ weak and only in the ADE; 3 ϭ initiated but not maintained. These constructs placed the endothelial cell precursor, liver, and thyroid enhancers between the Hex ATG and position Ϫ4262, the blood island enhancer between position ϩ27 and ϩ3016, the AVE/node/axial mesendoderm enhancer between position ϩ2950 and ϩ3367, and the element required for maintenance of Hex expression in the axial mesendoderm between positions ϩ2734 and ϩ3143 downstream of the Hex ATG. (B) Alignment of the mouse and human region B5. The sequence of the mouse region B had been previously placed on the GenBank database (Ghosh et al., 1999; Accession No. AF132550) . Sequence for the corresponding region in the human genome has also been placed on the database (Accession No. AL360222). The mouse (top line) and human (bottom line) region B5 were found to be 78.5% identical. Underlined are the positions of the possible SIP1, LEF1/TCF, and HNF3␤ binding motifs. The three possible HNF3␤ binding motifs have a 1-bp change in positions that appear important in the HNF3␤ consensus sequence (Overdier et al., 1994) and therefore may represent low-affinity sites. incubated with 2 ϫ 10 5 sperm, 5 l of egg extract, and 0.05 unit of restriction enzyme in 500 l of sperm dilution buffer at 15°C for up to 2 h prior to injection. In situ hybridizations were as described (Sive et al., 2000) . GFP plasmids were linearised with NotI and CAT plasmids were linearised with SalI.
Dissection of Mouse Embryos, X-Gal Staining, and Histology
F 0 embryos and embryos derived from transgenic mouse lines were collected and stained for ␤-galactosidase reporter activity as described (Hogan et al., 1994) or inspected for GFP activity using a fluorescein epifluorescence filter in a Zeiss Axiophot microscope. For histology, embryos were postfixed overnight in 4% paraformaldehyde. Embryos were washed in PBS, dehydrated through a graded ethanol series, embedded in paraffin wax, and sectioned. Sections were stained with hematoxylin-eosin as described previously (Kaufman, 1992) .
Genotyping
Live-born offspring were genotyped by PCR of tail DNA (Hogan et al., 1994) . F 0 embryos and embryos derived from transgenic lines were genotyped according to the minimal promoter and reporter construct that transgenic mice should carry. In some cases embryos were genotyped by PCR after lacZ staining as described (Hogan et al., 1994) . Mice and embryos carrying the Hex mutant allele(s) were genotyped according to Martinez Barbera et al. (2000) and those carrying the HNF3␤ mutant allele(s) were genotyped according to Ang and Rossant (1994) .
RESULTS
Distinct Regulatory Elements Control Hex Expression during Gastrulation and Organogenesis
In order to identify enhancers responsible for the transcriptional regulation of Hex, we constructed transgenes containing Hex genomic subregions and a GFP or lacZ reporter cassette driven by either the Hex promoter (Ghosh et al., 1999) or the human ␤-globin minimal promoter (Yee and Rigby, 1993) . We initially tested an 8.0-kb genomic fragment that included 4.2 kb of sequence upstream of the Hex ATG (containing the Hex endogenous promoter) and 3.8 kb downstream of the ATG (containing exons 1-3, introns 1 and 2, and 800 bp of intron 3; Fig. 1A , construct A). Initial screening was carried out by transient analysis of transgenic embryos recovered between 6.5 and 9.5 dpc, followed by more detailed expression analysis of permanent transgenic lines.
When embryos transgenic for fragment A (Fig. 1A) were analysed between 5.5 and 6.5 dpc, GFP expression was observed in the cells of the AVE (Figs. 2A-2G). Initially GFP was detected in a small group of cells at the distal tip of the egg cylinder ( Fig. 2A ) and then in a unilateral patch of cells adjacent to the distal tip ( Fig. 2B) . At 6.0 dpc GFP expression was observed in AVE cells that lie between the distal tip and the embryonic/extraembryionic boundary (Figs. 2C and 2D) and by 6.5 dpc in a larger population of AVE cells close to the embryonic/extraembryonic boundary ( Fig. 2E) .
At the late streak stage, GFP expression was observed in the AVE and at the anterior tip of the primitive streak (Figs. 2F and 2G) . At the neural plate and headfold stages, sites of expression include the ADE as well as more posterior node derivatives, such as the prechordal and notochordal plates (see later) and the nascent blood islands (Figs. 2H and 2I). By 8.5 dpc, GFP was most obvious in the notochord (see later), the foregut diverticulum, and the endothelial cell precursors ( Fig. 2J ). At 9.5 dpc all the characteristic sites of Hex expression could be seen with the GFP reporter, including the liver and thyroid primordia and the endothelial cell precursors (Fig. 2K ). Thus we conclude that this 8.0-kb fragment contains enhancers sufficient to drive Hex expression in the AVE, ADE, blood islands, liver, thyroid, and endothelial cell precursors.
In an attempt to identify a minimal region that contains the AVE and/or the ADE enhancer, a fragment containing a 3.5-kb intronic region downstream of the ATG (Fig. 1A , construct B) was tested. Transgenes containing region B showed lacZ expression in the AVE prior to gastrulation and in the AVE, axial mesendoderm (Figs. 3A-3G), and blood islands (data not shown) during gastrulation. Interestingly expression in the blood islands could only be seen in mice homozygous for this transgene. This difference in expression levels in the blood islands when compared to region A may be due to the absence of an element in fragment B that allows maximal expression in blood islands or to the difference in sensitivity or stability of lacZ compared with GFP. At 8.5 and 9.5 dpc expression is observed in the notochord and foregut diverticulum, but not in the thyroid primordium nor in the endothelial cell precursors (Figs. 3H-3K). At 10.5 dpc no expression is observed in the liver or thyroid primordia, nor in the endothelial cell precursors (data not shown), indicating that the regulatory elements that control Hex expression prior to and during gastrulation are distinct from those that control expression at the onset of organogenesis.
A 633-bp Minimal Fragment Contains the AVE and ADE Enhancer
The deletions depicted in Fig. 1A (B1-B7) were used to identify a minimal DNA fragment that is sufficient to drive reporter gene expression in the AVE and ADE. Reporter gene activity was monitored at 6.5 and 7.5 dpc from a minimal promoter driving GFP or ␤-galactosidase with the relevant enhancer fragment positioned downstream. B5 (ϩ2734 to ϩ3367 downstream of the Hex ATG, green oval in Fig. 1A ) was the smallest fragment that activated the same expression pattern in the AVE and in the axial mesendoderm as fragment B (Figs. 4A-4D). This region appeared to be highly conserved between mouse and humans. Whilst the overall identity of intron 3 between mouse and human was found to be 48%, within region B5 this identity was 78.5% (Fig. 1B) .
When smaller enhancer fragments were tested, a subset of expression or no expression was observed. With B6 (a 224-bp deletion at the 3Ј end of region B), a very small number of weakly stained cells were seen in the AVE at 6.5 dpc (Fig. 4E ). In some cases these cells were abnormally located within the visceral endoderm overlying the embryonic region. At 7.5 dpc the expression of the reporter gene was restricted to the ADE (Figs. 4F-4H).
The observation that sequences at the 3Ј end of B5 are required for full expression in both the AVE and the axial mesendoderm is consistent with the observation that B4, which removes slightly more of this region, is not expressed in either of these tissues (n ϭ 8 at 6.5 dpc and n ϭ 5 at 7.5 dpc). Interestingly, construct B4 reproducibly (n ϭ 5) drove GFP expression in the nascent blood islands. This places the enhancer that drives blood island expression between positions ϩ27 and ϩ3016 downstream of the Hex ATG (red oval in Fig. 1A ).
Identification of a Sequence Required for Maintenance of Hex Expression
When ␤-galactosidase activity of a 5Ј 216-bp deletion of B5 (B7) was analysed at 6.5 dpc, staining was apparent in the AVE (Fig. 4I ). At 7.0 dpc lacZ expression was observed in the AVE as well as in the node and the axial mesendoderm (Fig. 4J ). This expression in the axial mesendoderm was lost or greatly reduced later during gastrulation (Figs. 4K and 4L) . This observation suggests that the deleted region contains elements that are necessary for the maintenance of Hex expression in the ADE (pink oval in Fig. 1A ), but not for its initiation in the AVE or axial mesendoderm. Therefore, the analysis of deletion variants of B5 suggests that although the initiation of Hex expression in the AVE and axial mesendoderm requires common regions, the maintenance of this expression may be regulated independently in these tissues.
Identification of a Repressor Element That Regulates the Correct Expression of Hex in the Axial Mesendoderm
When reporter gene expression driven by constructs carrying the minimal AVE/ADE enhancer (Fig. 1A) is compared with the expression of Hex during gastrulation, a number of significant differences can be observed. As men-tioned above, at the midstreak stage, Hex is expressed in the AVE and in the anterior tip of the primitive streak, a region of the embryo that probably corresponds to the node precursors (Tam and Steiner, 1999) . By the late streak stage Hex expression extends anteriorly from the node to the embryonic/extraembryonic junction. Once the neural groove is evident, transcripts are restricted to the ADE and there is no expression in the node or in non-ADE axial mesendoderm (Thomas et al., 1998) .
At the mid-and late streak stages of gastrulation the expression pattern of the GFP reporter transgene A or the lacZ transgenes B, B2, and B5 are similar to Hex endogenous expression ( Figs. 2F and 3B) . In contrast, by the neural plate stage GFP/lacZ expression is seen not only in the ADE (as occurs with Hex) but also in more posterior axial mesendoderm including the node itself (Figs. 2H and 2I, and 4B and 4C) . This expression persists through the headfold stages. By 8.5 dpc expression is seen in the anterior foregut and notochord (Figs. 2J, 3H, and 3I), indicating that reporter gene expression has been maintained in all ventral node derivatives. The uniform strength of expression in all these tissues, the large number of cells expressing the reporter gene, and the time elapsed from the onset of endogenous Hex expression in the node (over 48 h) make it very unlikely that this later transgene expression domain is due to perdurance of GFP or ␤-galactosidase proteins. This ectopic expression may reflect the absence of a silencing element responsible for downregulating Hex in non-ADE axial mesendoderm once the ADE has formed.
The Expression of a Reporter Transgene Linked to the Intronic Enhancer Is Lost in an HNF3␤ Mutant Background
The HNF3/fork head family member HNF3␤ is an early marker of the node and axial mesendoderm. Because the transgenes A, B, B2, and B5 show expression throughout the axial mesendoderm, it was of interest to analyse the expression of the intronic enhancer in the context of an HNF3␤ mutant background. The primary defect in HNF3␤ null mutants is the absence of the node and its derivatives, although posterior definitive endodermal cells are formed (Ang and Rossant, 1994; Weinstein et al., 1994) . When HNF3␤ mutants containing fragment B were analysed at 7.5 dpc, no lacZ expression was observed ( Figs. 5B and 5C ). This lack of transgene expression indicates that at this stage of development the cells normally expressing this transgene are exclusively node derived and the observation opens up the possibility that HNF3␤ acts upstream of Hex in the node and/or ADE.
Targeted Deletion of the AVE and ADE Enhancer Abolishes Expression in These Tissues but Does Not Affect Endothelial Cell, Liver, or Thyroid Expression
To test in more detail the ability of the AVE/ADE enhancer to drive expression in the AVE and ADE, we made use of a targeted deletion at the Hex locus (Martinez Barbera et al., 2000) . This mutation was generated using an IRES lacZ cassette to replace most of exon 1, all of exon 2 and 3, and the intronic region that contains the AVE/ADE enhancer ( Fig. 1A) . When heterozygous or homozygous embryos carrying this deletion allele were analysed for reporter gene expression, no lacZ staining was observed in the AVE or in the ADE (Figs. 6A and 6B) (Martinez Barbera et al., 2000) . This indicates that the intronic enhancer not only is sufficient to drive reporter gene expression in the AVE and ADE, but also is necessary for initiating Hex expression in these tissues.
In contrast, at 8.5 dpc, ␤-galactosidase activity was seen in the foregut diverticulum and in the endothelial cell precursors. At 9.5 dpc expression was present in the liver and thyroid primordia as well as in the endothelial cell precursors (Fig. 6C ). This confirms that the enhancers required to drive expression in these tissues lie outside this 3.5-kb intronic region (orange oval in Fig. 1A) .
In order to test the requirement for Hex in autoregulation, the fragment B transgene was assayed in Hex null embryos. At 7.0 dpc no clear difference in transgene expression in the AVE and ADE was observed between Hex mutants ( Fig. 6D ) and wild-type embryos (Fig. 3B ). However, at the neural plate stage, a clear decrease in lacZ expression in the most anterior aspect of the axial mesendoderm was observed between Hex mutants ( Fig. 6E ) and wild-type embryos (Fig. 3E ). This region presumably corresponds to the ADE, supporting the conclusion that in these mutants this tissue either fails to maintain Hex expression or is lost (Martinez Barbera et al., 2000) . By 9.0 dpc no significant difference in the expression of fragment B was observed between mutant (Fig. 6F ) and wild-type embryos (Fig. 3J ).
The Mouse Hex Enhancers Drive Expression in Similar Structures in Xenopus laevis
To test whether the function of the mouse AVE/ADE enhancer is evolutionary conserved, a B2 reporter construct was introduced into Xenopus laevis embryos. The intronic subregion B2 (Fig. 1A) was linked to a CAT reporter cassette driven by the cytoskeleton actin minimal promoter. As occurs in mice, fragment B2 drives expression in the anterior endoderm, in both deep and suprablastoporal domains, of the gastrulating embryo ( Figs. 7A and 7B) . These regions are assumed to be equivalent to the mouse AVE and ADE, respectively (Jones et al., 1999) . Interestingly this enhancer shows no expression at the tadpole stage (data not shown).
Given the conservation of the AVE/ADE enhancer, we next tested the expression in X. laevis of the other Hex enhancers identified in this study. For this purpose the expression of the large genomic subregion A (where the first Hex exon is replaced with GFP; Fig. 1A ) was analysed. As with the intronic enhancer alone, expression was observed in the anterior endoderm of gastrulating embryos (data not shown), but unlike fragment B2, at the tadpole stage expression was also observed in the developing liver, thyroid, and vasculature ( Figs. 7C and 7D) . Indeed, the reporter showed expression similar to that of endogenous Xhex in the posterior cardinal vein, the intersomitic veins, the developing thyroid, and the forming hepatic diverticulum (Newman et al., 1997) . By stage 32 GFP fluorescence becomes undetectable and the reporter gene expression was analysed by in situ hybridization. At this stage the Hex enhancers drive expression in the developing thyroid and in the vasculature (Figs. 7E and 7F) . These results demonstrate that the enhancers controlling Hex expression in the liver, thyroid, and vasculature are distinct from those required for expression in the deep endoderm and provide evidence for an evolutionary conservation of these enhancers in vertebrates.
DISCUSSION
Anterior patterning, liver, and thyroid formation are controlled by highly dynamic patterns of Hex expression (Martinez Barbera et al., 2000) . Here we have shown that these functions are regulated by a number of distinct cis-acting regulatory elements. Thus a 4.2-kb upstream region was found to drive expression in endothelial cell precursors, as well as in the liver and thyroid primordia, whereas a 633-bp intronic enhancer confers expression in the AVE, node, and axial mesendoderm. The analysis of the AVE/node/axial mesendoderm enhancer raises three issues that will be discussed further: first that common regions may be required to initiate Hex expression in the AVE and axial mesendoderm; second that the maintenance of Hex expression in these tissues may be regulated independently; and finally that a repressor element downregulates Hex expression from the node once the ADE has formed.
Common Regions Are Required to Initiate Hex Expression in the AVE and ADE
In this report we identify a minimal 633-bp fragment (region B5, Fig. 1A) , contained within intron 3 of the Hex locus, that confers expression in both the AVE and the node and its derivatives. Targeted deletion of this enhancer region from the endogenous locus leads to loss of expression in both these tissues, showing the essential function of this fragment. In Xenopus and zebrafish, nodal-related signals (Osada and Wright, 1999; Zorn et al., 1999) and Wnt/␤catenin signals (Ho et al., 1999; Zorn et al., 1999) have been implicated in Hex regulation. Similarly, in mouse, Hex expression is lost in Smad2 (Heyer et al., 1999) and ␤-catenin mutants (Huelsken et al., 2000) . Expression driven by the intronic enhancer identified here (region B) is also lost in nodal and Smad2 mutants (E. J. Robertson, personal communication) as well as in mutants for HNF3␤ (Fig. 5) , which has been shown to genetically interact with nodal (Varlet et al., 1997) . A number of potential SIP1 (a proposed partner for Smad2) (Verschueren et al., 1999) , LEF/Tcf, and HNF3␤ binding motifs appear scattered across region B5 (Fig. 1B) , suggesting that the nodal and Wnt/␤catenin signalling pathways may be controlling the AVEand ADE-specific expression of Hex.
The observation that the minimal 633-bp region confers expression in the AVE as well as in the node and its derivatives suggests that common mechanisms may exist to control gene expression in these tissues. This conclusion is supported by the observation that transcriptional regulation in these tissues was not uncoupled in any of our deletions. For example, B6 and B4 lead to a synchronous reduction or elimination of expression in both the AVE and the axial mesendoderm ( Figs. 1 and 4) . Similarly, AVE and ADE expression are both lost in the targeted mutation that removes a region containing the 633-bp minimal enhancer. These observations contrast with those made for nodal (Norris and Robertson, 1999) , where distinct regulatory elements control expression in the node as opposed to the visceral endoderm. It is possible that this difference occurs because nodal lies nearer the top of the hierarchy that controls gene expression in both these signalling centres. Our findings with respect to Hex, combined with the fact that most of the genes identified so far that are expressed in the AVE are also expressed in the node and/or its derivatives, strongly suggest that the same transcriptional regulation operates in both these tissues.
Distinct Mechanisms Are Required to Maintain Hex Expression in the AVE and ADE
While there may be common transcriptional regulation of the initiation of Hex expression in both the AVE and the ADE, distinct molecular mechanisms are responsible for the maintenance of Hex expression in these tissues. Analysis of B7 (a 216-bp deletion at the 5Ј end of B5; Figs. 1A and 4) revealed that AVE expression is apparently normal in transgenic embryos, but expression in the node and its derivatives is not maintained. Thus the deleted region contains elements essential for the maintenance of Hex expression in the axial mesendoderm. Similarly, analysis of the AVE and ADE enhancer activity in HexϪ/Ϫ embryos revealed that expression was normal in the AVE and appropriately induced in the axial mesendoderm, but was later downregulated or lost from the anterior axial mesendoderm. Taken together, these results suggest that common regions are required to initiate Hex expression in the AVE and ADE but that there are also distinct mechanisms operating to produce differential expression in these two tissues. The downregulation or inactivity of fragment B in HexϪ/Ϫ embryos is an indication that Hex itself may be contributing to produce this differential gene expression between the AVE and ADE.
A number of studies in other organisms have invoked a requirement for antagonising BMP signals to maintain Hex expression. In Xenopus, Bmp4 inhibition was suggested to be necessary to maintain Hex expression (Zorn et al., 1999) . Similarly, in zebrafish swirl/bmp2 mutants, Hex expression is initiated normally, but during gastrulation a gradual ventral expansion of Hex expression occurs, so that by the end of gastrulation Hex appears to be expressed throughout the yolk syncytial layer. Furthermore, in embryos lacking the BMP antagonist Chordino, a gradual reduction of Hex expression occurs during gastrulation (Ho et al., 1999) . Interestingly, in mouse, the BMP antagonists chordin and noggin are both required for correct gene expression in the ADE (Bachiller et al., 2000) , showing that blocking BMP signalling is required to maintain Hex expression. Thus antagonizing BMP signals may allow the intronic element to maintain Hex expression in the ADE.
A Repressor Element Restricts Hex Expression in the Node and Axial Mesendoderm
It has been proposed that the mouse node contains a resident stem cell population that gives rise to the axial mesendoderm (Beddington, 1994; Lawson et al., 1991; Tam and Behringer, 1997) . In support of this argument, when the mouse node is grafted to an ectopic location, it gives rise to a second axis in which the ectopic notochord is derived solely from the donor node (Beddington, 1994) . The results presented here suggest that a repressor element downregulates Hex expression in these progenitor cells once the most anterior axial mesendoderm (the ADE) has formed.
All node and axial mesendoderm expression driven by the intronic enhancer identified here (region B) is lost in HNF3␤ mutants (Fig. 5) , which lack a recognisable node and its derivatives (Ang and Rossant, 1994; Weinstein et al., 1994) . This observation confirms that the ectopic expression domain given by the intronic enhancer is node-derived. Consistent with the notion that Hex is expressed in the node stem cell population, the axial mesendoderm expression of Cerrl is lost in Hex mutants (Martinez Barbera et al., 2000) . Given that Cerrl expression extends further posteriorly and laterally in the axial mesendoderm than the Hex expression domain, this suggests that Hex may promote Cerrl expression in the node stem cell population.
Why should suppression of Hex activity be important for patterning? During late gastrulation, the expression patterns of a number of genes reveal a fine anatomical subdivision within the superficially homogeneous population of axial mesendoderm (Tam and Behringer, 1997) . The most rostral region, underlying the prospective forebrain, expresses, Hex, Cerrl, Gsc, Shh, and HNF3␤ (Belo et al., 1997; Biben et al., 1998; Chiang et al., 1996; Filosa et al., 1997; Shawlot et al., 1999; Thomas et al., 1997 Thomas et al., , 1998 . By contrast genes such as Lim1, Otx2, HNF3␤, Shh, and Bmp7 are expressed not only in this region but also in the axial In situ hybridization for GFP RNA driven by fragment A in stage 32 embryos. GFP RNA expression can be detected in the eyes and midbrain area of both control, uninjected embryos (not shown), and injected embryos and is therefore considered background. (E) Expression of GFP RNA driven by Hex regulatory regions in a cleared embryo is observed in the ventral region of the head, in the heart (black arrow), and in the intersomitic veins. (F) Represents a higher magnification of a stage 32 embryo showing more specifically expression in the pronephric sinus and cardinal vein (red arrow). st ϭ stage. mesendoderm which underlies the prospective midbrain and hindbrain (Acampora et al., 1995; Ang et al., 1996; Belo et al., 1998; Chiang et al., 1996; Filosa et al., 1997; Lyons et al., 1995; Matsuo et al., 1995; Perea-Gomez et al., 1999) . At a more posterior level, the notochord expresses Brachyury, HNF3␤, Shh, and Noggin (Chiang et al., 1996; Filosa et al., 1997; McMahon et al., 1998; Wilkinson et al., 1990) . Genetic and grafting experiments have confirmed that these fine subdivisions are important for the correct patterning of the neural tube (Ang and Rossant, 1993; Camus et al., 2000; Martinez Barbera et al., 2000) . For example, loss of Hex, which is only expressed in the most anterior axial mesendoderm, leads to forebrain truncations (Martinez Barbera et al., 2000) , whilst mutation of Lim1, which is expressed in a wider mesendoderm domain, leads to truncations that reach the third rhombomere of the hindbrain (Shawlot and Behringer, 1995) . The specific requirement for Hex during forebrain formation, as well as the need to maintain fine pattern in the axial mesendoderm, may explain the need for a repressor that downregulates Hex in the node once the ADE has formed. The activity of this repressor may thus prevent posterior tissue from taking on anterior character. This conclusion is consistent with the observation that overexpression of Hex in Xenopus leads to increased rostral identity at the expense of trunk organizer activity (Brickman et al., 2000) .
The identification of a evolutionarily conserved AVE/ ADE enhancer will provide a powerful tool, allowing one to misexpress genes in these tissues, as well as providing a means to identify the molecular pathways that lie upstream of Hex in the AVE as well as in the node and its derivatives.
